Physician profile
Ritu Khullar
NPI 1912167701
$614.91
in general payments reported to CMS, 2019-2025
12 companies · $19.82 in 2025
The $19.82 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.38 · 2020: $63.66 · 2021: $129 · 2022: $130 · 2023: $95.41 · 2024: $147 · 2025: $19.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $262.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $167.19 | 2019-2025 | Doc Band |
| Aytu Biopharma, INC. | $87.80 | 2020-2023 | |
| Pfizer INC. | $78.49 | 2021-2024 | |
| Cumberland Pharmaceuticals, INC. | $65.12 | 2021-2024 | Kristalose |
| Sanofi Pasteur INC. | $52.38 | 2019-2024 | |
| Alk-Abello, INC | $45.86 | 2024 | Odactra, Ragwitek, Grastek |
| Kaleo, INC. | $29.84 | 2022-2023 | Auvi-Q |
| Baxter Healthcare | $26.59 | 2022 | |
| Phadia US INC. | $18.16 | 2024 | Immunocap |
| Merck Sharp & Dohme LLC | $15.54 | 2023 | Vaqta, Gardasil 9, Vaxneuvance |
| Sobi, INC | $15.00 | 2022 | |
| Genentech USA, INC. | $12.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ritu Khullar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.